Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Kamiya, S. Ikushima, K. Kondo, K. Satake, M. Inomata, A. Moriya, T. Ando (Tokyo, Japan). Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis. Eur Respir J 2012; 40: Suppl. 56, 415

Member's Comments

No comment yet.

Related content which might interest you: Performance outcomes of standardized antigen-driven IFN-g release assays for the diagnosis of active TB in a high burden setting Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Comparative performance of interferon gamma release assays in detection of latent tuberculosis infection among health-care professionals Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 False-negative interferon gamma release assay results in active tuberculosis: a TBNET study Source: Eur Respir J 2015; 45: 279-283 Year: 2015 An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy Source: Eur Respir J 2014; 44: 1369-1372 Year: 2014 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 The value of cellular interferon – gamma assays for TB diagnosis in immunocompetent and immunocompromised patients Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Adherence to national guidelines for interferon gamma release assay in diagnosis of mycobacterium tuberculosis Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015 Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Support of ex vivo IFN-gamma release assays in the diagnosis of tuberculosis infection in HIV/AIDS patients Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Impact of interferon-? release assay on the latent tuberculosis cascade of care: a population-based study Source: Eur Respir J , 49 (3) 1601546; DOI: 10.1183/13993003.01546-2016 Year: 2017 Use of interferon-gamma release assays in diagnosis of active TB infection - Experience of a rural UK hospital Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 LATE-BREAKING ABSTRACT: The performance of flow cytometry in the diagnosis of latent tuberculosis infection in patients under treatment with anti-TNFa and other biological agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 A prospective longitudinal study evaluating a T-cell-based assay for latent tuberculosis infection in healthcare workers in a general hospital in Beijing Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013